Published in Arterioscler Thromb Vasc Biol on June 21, 2012
Methylation of the SLC6a2 gene promoter in major depression and panic disorder. PLoS One (2013) 0.96
Genetics and epigenetics of arrhythmia and heart failure. Front Genet (2013) 0.94
Sympathetic dysfunction in vasovagal syncope and the postural orthostatic tachycardia syndrome. Front Physiol (2014) 0.87
Update on the theory and management of orthostatic intolerance and related syndromes in adolescents and children. Expert Rev Cardiovasc Ther (2012) 0.85
Cognitive impairments associated with CFS and POTS. Front Physiol (2013) 0.84
Cognitive function, health-related quality of life, and symptoms of depression and anxiety sensitivity are impaired in patients with the postural orthostatic tachycardia syndrome (POTS). Front Physiol (2014) 0.83
Neuronal and hormonal perturbations in postural tachycardia syndrome. Front Physiol (2014) 0.82
Effects of norepinephrine reuptake inhibition on postural tachycardia syndrome. J Am Heart Assoc (2013) 0.81
Chromatin context and ncRNA highlight targets of MeCP2 in brain. RNA Biol (2013) 0.80
Atomoxetine affects transcription/translation of the NMDA receptor and the norepinephrine transporter in the rat brain--an in vivo study. Drug Des Devel Ther (2013) 0.78
Neurovisceral phenotypes in the expression of psychiatric symptoms. Front Neurosci (2015) 0.78
REM sleep and its Loss-Associated Epigenetic Regulation with Reference to Noradrenaline in Particular. Curr Neuropharmacol (2016) 0.76
NET silencing by let-7i in postural tachycardia syndrome. JCI Insight (2017) 0.75
The aetiopathogenesis of fatigue: unpredictable, complex and persistent. Br Med Bull (2016) 0.75
A polymorphism in the norepinephrine transporter gene is associated with affective and cardiovascular disease through a microRNA mechanism. Mol Psychiatry (2016) 0.75
Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes. Nat Genet (2007) 11.09
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet (2009) 10.53
Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension. J Appl Physiol (1985) (2010) 9.76
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13
Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat Genet (2005) 3.98
Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet (2011) 3.46
Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation (2013) 3.44
Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation. Hypertension (2003) 3.29
Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med (2009) 2.97
Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation (2011) 2.88
Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions. Arterioscler Thromb Vasc Biol (2004) 2.76
Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy. Arch Gen Psychiatry (2008) 2.43
Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension (2006) 2.41
Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes (2009) 2.34
Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J Immunol (2010) 2.32
Quality assessment of maize assembled genomic islands (MAGIs) and large-scale experimental verification of predicted genes. Proc Natl Acad Sci U S A (2005) 2.27
Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol (2009) 2.04
Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension (2010) 2.01
Genetic variation in selenoprotein S influences inflammatory response. Nat Genet (2005) 2.00
Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy. J Am Soc Nephrol (2005) 1.95
Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension (2007) 1.90
Genetic dissection of intermated recombinant inbred lines using a new genetic map of maize. Genetics (2006) 1.89
A strategy for assembling the maize (Zea mays L.) genome. Bioinformatics (2004) 1.83
Renal denervation: a potential new treatment modality for polycystic ovary syndrome? J Hypertens (2011) 1.80
The sympathetic nervous system and the metabolic syndrome. J Hypertens (2007) 1.80
Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. Eur Heart J (2005) 1.80
Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res (2012) 1.78
NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis. Circulation (2013) 1.78
Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells. Circ Res (2012) 1.78
Autonomic control of the heart and renal vascular bed during autonomic dysreflexia in high spinal cord injury. Clin Auton Res (2002) 1.75
The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J (2012) 1.74
Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. J Clin Endocrinol Metab (2009) 1.72
B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ Res (2011) 1.67
Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol (2012) 1.66
Single-molecule studies of repressor-DNA interactions show long-range interactions. Proc Natl Acad Sci U S A (2005) 1.60
Decreased catecholamine degradation associates with shock and kidney injury after cardiac surgery. J Am Soc Nephrol (2009) 1.60
Persistence of muscle sympathetic nerve activity during vasovagal syncope. Eur Heart J (2010) 1.56
Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial. J Natl Cancer Inst (2011) 1.56
EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone. J Bone Miner Res (2013) 1.55
Similarity and divergence of phylogenies, antimicrobial susceptibilities, and virulence factor profiles of Escherichia coli isolates causing recurrent urinary tract infections that persist or result from reinfection. J Clin Microbiol (2012) 1.53
Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor. Stress (2007) 1.52
Epigenetic phenomena linked to diabetic complications. Nat Rev Endocrinol (2010) 1.51
Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA (2012) 1.50
Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs. Oncogene (2005) 1.47
Elevated Beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma. Autophagy (2010) 1.47
Rilmenidine sympatholytic activity preserves mental stress, orthostatic sympathetic responses and adrenaline secretion. J Hypertens (2004) 1.46
Increased cardiac sympathetic drive in renovascular hypertension. J Hypertens (2002) 1.46
Nearly identical paralogs: implications for maize (Zea mays L.) genome evolution. Genetics (2006) 1.45
Analysis of the IGF2/H19 imprinting control region uncovers new genetic defects, including mutations of OCT-binding sequences, in patients with 11p15 fetal growth disorders. Hum Mol Genet (2009) 1.45
Angiotensin II and norepinephrine release: interaction and effects on the heart. J Hypertens (2005) 1.44
Interactions between leptin and the human sympathetic nervous system. Hypertension (2003) 1.44
Corticosteroid Therapy Benefits Septic Mice With Adrenal Insufficiency But Harms Septic Mice Without Adrenal Insufficiency. Crit Care Med (2015) 1.39
Glia as a therapeutic target: selective suppression of human amyloid-beta-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration. J Neurosci (2006) 1.39
HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages. J Clin Invest (2003) 1.39
Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation (2003) 1.38
Plasma lipid profiling in a large population-based cohort. J Lipid Res (2013) 1.35
High-mobility group box protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol (2010) 1.32
Population fitness and the regulation of Escherichia coli genes by bacterial viruses. PLoS Biol (2005) 1.32
Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men. Cancer Sci (2011) 1.32
New drugs, procedures, and devices for hypertension. Lancet (2012) 1.32
Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure. Pharmacogenetics (2003) 1.32
Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation. PLoS One (2011) 1.30
Understanding the role of transforming growth factor-beta1 in intimal thickening after vascular injury. Cardiovasc Res (2007) 1.30
Epigenetics: mechanisms and implications for diabetic complications. Circ Res (2010) 1.26
Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition. Hum Mol Genet (2008) 1.26
Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PLoS One (2013) 1.24
Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Proc Natl Acad Sci U S A (2005) 1.24
Effects of breaking up prolonged sitting on skeletal muscle gene expression. J Appl Physiol (1985) (2012) 1.24
Postradiation nasopharyngeal necrosis in the patients with nasopharyngeal carcinoma. Head Neck (2009) 1.24
Retracted FOXO1 regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle. J Biol Chem (2007) 1.22
Recurrent postural vasovagal syncope: sympathetic nervous system phenotypes. Circ Arrhythm Electrophysiol (2011) 1.22
Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Res (2011) 1.22
Chronic mental stress is a cause of essential hypertension: presence of biological markers of stress. Clin Exp Pharmacol Physiol (2008) 1.21
RNA interference and potential therapeutic applications of short interfering RNAs. Cancer Gene Ther (2005) 1.21
Chemerin, a novel adipokine in the regulation of angiogenesis. J Clin Endocrinol Metab (2010) 1.20
Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation (2011) 1.18
Development of a novel therapeutic suppressor of brain proinflammatory cytokine up-regulation that attenuates synaptic dysfunction and behavioral deficits. Bioorg Med Chem Lett (2006) 1.18
Types and frequencies of sequencing errors in methyl-filtered and high c0t maize genome survey sequences. Plant Physiol (2004) 1.18
Deep sequencing reveals increased DNA methylation in chronic rat epilepsy. Acta Neuropathol (2013) 1.18
GammaH2AX as a molecular marker of aging and disease. Epigenetics (2010) 1.16
Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms. Nat Rev Nephrol (2010) 1.16
DNA sequence-based "bar codes" for tracking the origins of expressed sequence tags from a maize cDNA library constructed using multiple mRNA sources. Plant Physiol (2003) 1.16